SEE THE ONE
IN A BILLION.
Single cell diagnostics aiming to expedite care when it matters.
From whole blood to antibiotic susceptibility test (AST) in hours, expediting time to optimal treatment to save patients’ lives.
We develop direct-from-blood diagnostic solutions leveraging breakthroughs in live-cell imaging and AI-powered analysis.
Detect as few as 1 to 100 pathogens in a single 10 mL blood sample
SPLENDID™ exposes the unseen in minutes to drive clinical action.
Detect 1 pathogen among 50 billion host cells.
See what’s hiding in a 10 mL blood sample
-
![A digital illustration of red blood cells on a pink background.]()
~50 Billion
Red Blood Cells
(6–8 µm)
-
![Illustration of bacteria, including clusters of purple spherical bacteria and blue rod-shaped bacteria, on a blue background.]()
1-100
Pathogens
(1–2 µm)
-
![Illustration of a human white blood cell with its nucleus visible.]()
50-100 M
White Blood Cells
(12–17 µm)
-
![A group of purple, spiky sea shells on a light purple background.]()
~3 Billion
Platelets
(2–4 µm)
FROM BLOOD DRAW TO DIAGNOSIS IN MINUTES
SPLENDID™ Isolates & Characterizes Living Cells.
Culture-free, ultra-rapid platform for single-cell isolation and phenotypic characterization.
Empower clinicians with timely and accurate diagnostics
Automated sample handling directly from vacutainer tube
Life-saving results in the first hours of treatment
-
Isolate pathogens directly from patient samples within minutes
-
Label-free methods utilizing novel super-resolution, time-lapse imaging of captured cells
-
AI-powered image analysis with proprietary classification and characterization algorithms
SPLENDID™ is under development and not FDA approved for clinical diagnostics.
SPLENDID™ collapses a 2-5 day process into 1-3 hours
Patients can’t afford to wait.
BY THE NUMBERS: SEPSIS STATISTICS IN THE U.S. (2021)
>30 M
Blood Cultures
2.5 M
Patients Diagnosed
>350 K
Patient
Deaths
>$100 B
Healthcare
Costs
SOURCES: Patel et al., BMJ Open Qual. (2025); Global Sepsis Alliance; Sepsis Alliance; Buchman et al., Crit. Care Med (2020)
WHY ULTRA-FAST RESULTS MATTER
Critically ill patients can’t wait days for results, and doctors can’t wait to make treatment decisions.
Every hour appropriate treatment is delayed increases a patient’s risk of developing complications and reduces the chance of survival.
Empowering Clinicians with Actionable Results
-
The Platform
Explore how SPLENDID™ delivers clinically actionable results in minutes.
-
The Breakthroughs
The innovations powering SPLENDID™ to see the rare pathogen in blood samples.
OUR MISSION
Provide clinically actionable results to personalize patient care in minutes instead of days.
Sepsis takes a life every 2.8 seconds globally, yet doctors must wait days for definitive answers.
We close the gap between sample and answer to guide patient care, pioneering diagnostics that are faster, smarter, and clinically actionable.
BLASTID is led by diagnostic veterans, esteemed clinicians, & world-renowned scientists. We are a driven team united to solve a problem that kills >20 million people every year.
SOURCE: Global Sepsis Alliance
-
Launched through a global vision to defeat Antimicrobial Resistance (AMR) through transformative solutions.
LEARN MORE -
The operators, engineers, and scientists building SPLENDID™, and the pioneering advisors supporting BLASTID.
MEET US -
If you want to transform diagnostics, connect with us.
SEE OPEN POSITIONS
BLASTID spun-out of Harvard to defeat antimicrobial resistance through transformative clinical solutions with support from the ARPA-H DARTS program.
Our Partners & Collaborators
Ready to see one in a billion?
Partner with us today.
Connect with us.